TRxADE HEALTH, Inc. Stock price

Equities

MEDS

US89846A4058

Internet Services

Market Closed - Nasdaq 04:30:00 2024-03-28 pm EDT 5-day change 1st Jan Change
10.24 USD +7.23% Intraday chart for TRxADE HEALTH, Inc. -52.70% +97.06%
Sales 2021 9.89M Sales 2022 11.45M Capitalization 3.75M
Net income 2021 -5M Net income 2022 -3M EV / Sales 2021 1.76 x
Net cash position 2021 1.87M Net Debt 2022 450K EV / Sales 2022 0.37 x
P/E ratio 2021
-3.61 x
P/E ratio 2022
-0.98 x
Employees 34
Yield 2021 *
-
Yield 2022
-
Free-Float 71.92%
More Fundamentals * Assessed data
Dynamic Chart
1 day+7.23%
1 week-52.70%
Current month+7.56%
1 month+20.47%
3 months+102.37%
6 months+45.45%
Current year+97.06%
More quotes
1 week
8.53
Extreme 8.53
15.91
1 month
7.79
Extreme 7.79
44.56
Current year
3.69
Extreme 3.69
44.56
1 year
3.69
Extreme 3.69
44.56
3 years
3.69
Extreme 3.69
162.30
5 years
3.69
Extreme 3.69
174.00
10 years
3.69
Extreme 3.69
265.50
More quotes
Managers TitleAgeSince
Founder 49 05-07-14
Chief Executive Officer 53 05-07-14
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Chief Executive Officer 53 05-07-14
Director/Board Member 62 16-08-23
Director/Board Member 51 23-07-30
More insiders
Date Price Change Volume
24-03-28 10.24 +7.23% 113,383
24-03-27 9.55 +2.91% 65,680
24-03-26 9.28 -2.42% 136,511
24-03-25 9.51 -60.49% 266,650
24-03-22 24.07 +11.18% 108,326

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
TRxADE Health, Inc. provides a technology-enabled health services platform. The Company is focused on digitalizing the retail pharmacy and health services experience by optimizing drug procurement, the prescription journey, access to physicians in the patient’s home and patient engagement in the United States. The Company’s segments include Trxade, Inc., Integra Pharma Solutions, LLC (IPS) and Superlatus. Trxade, Inc. segment provides a web-based pharmaceutical marketplace platform-business to business (B2B) sales. IPS is a licensed pharmaceutical wholesaler and sells brand, generic and non-drug products to customers. The Superlatus segment holds Sapientia’s intellectual property for advanced food extrusion technology and The Urgent Company, which is a manufacturer of ice cream that is animal product-free, vegan, lactose-free, and made with plant-B2B sales. Its subsidiaries include Community Specialty Pharmacy, LLC, Alliance Pharma Solutions, LLC, Bonum Health, LLC and others.
More about the company
  1. Stock
  2. Equities
  3. Stock TRxADE HEALTH, Inc. - Nasdaq